Denatonium as a Bitter Taste Receptor Agonist Modifies Transcriptomic Profile and Functions of Acute Myeloid Leukemia Cells.

acute myeloid leukemia bitter compounds bitter taste receptors bone marrow microenvironment denatonium benzoate

Journal

Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867

Informations de publication

Date de publication:
2020
Historique:
received: 21 02 2020
accepted: 15 06 2020
entrez: 15 8 2020
pubmed: 15 8 2020
medline: 15 8 2020
Statut: epublish

Résumé

The contribution of cell-extrinsic factors in Acute Myeloid Leukemia (AML) generation and persistence has gained interest. Bitter taste receptors (TAS2Rs) are G protein-coupled receptors known for their primary role as a central warning signal to induce aversion toward noxious or harmful substances. Nevertheless, the increasing amount of evidence about their extra-oral localization has suggested a wider function in sensing microenvironment, also in cancer settings. In this study, we found that AML cells express functional TAS2Rs. We also highlighted a significant association between the modulation of some TAS2Rs and the poor-prognosis AML groups, i.e.,

Identifiants

pubmed: 32793492
doi: 10.3389/fonc.2020.01225
pmc: PMC7393209
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1225

Subventions

Organisme : Medical Research Council
ID : MC_PC_12009
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_PC_17230
Pays : United Kingdom

Commentaires et corrections

Type : ErratumIn

Informations de copyright

Copyright © 2020 Salvestrini, Ciciarello, Pensato, Simonetti, Laginestra, Bruno, Pazzaglia, De Marchi, Forte, Orecchioni, Martinelli, Bertolini, Méndez-Ferrer, Adinolfi, Di Virgilio, Cavo and Curti.

Références

PLoS One. 2014 Sep 16;9(9):e107224
pubmed: 25226385
J Neurophysiol. 2002 Jun;87(6):3152-5
pubmed: 12037215
Int J Biochem Cell Biol. 2016 Aug;77(Pt B):197-204
pubmed: 27032752
Nat Med. 2010 Nov;16(11):1299-304
pubmed: 20972434
Ther Adv Hematol. 2016 Feb;7(1):40-51
pubmed: 26834953
Eur J Pharmacol. 2020 Apr 5;872:172951
pubmed: 32006560
Genome Biol. 2008 Oct 13;9(10):R149
pubmed: 18847512
Oncotarget. 2017 Aug 3;8(39):66226-66236
pubmed: 29029506
Immunol Invest. 2012;41(6-7):765-97
pubmed: 23017145
J Cell Biochem. 2009 Jan 1;106(1):73-82
pubmed: 19009557
Blood. 2012 Jan 5;119(1):217-26
pubmed: 22053107
Mol Biol Cell. 2003 May;14(5):2005-15
pubmed: 12802071
Cancer. 2019 Mar 1;125(5):712-725
pubmed: 30480765
Front Immunol. 2018 Dec 11;9:2949
pubmed: 30619309
Acta Physiol (Oxf). 2012 Feb;204(2):158-68
pubmed: 21481196
Genes Dev. 1993 May;7(5):812-21
pubmed: 8491378
J Clin Invest. 2014 Mar;124(3):1393-405
pubmed: 24531552
Curr Opin Clin Nutr Metab Care. 2014 Jul;17(4):379-85
pubmed: 24763065
PLoS One. 2017 May 3;12(5):e0176851
pubmed: 28467517
Mol Carcinog. 1993;8(4):209-13
pubmed: 8280368
EMBO J. 1994 Sep 15;13(18):4302-10
pubmed: 7523110
J Pharm Sci. 2013 Dec;102(12):4444-54
pubmed: 24129966
Science. 2009 Aug 28;325(5944):1131-4
pubmed: 19628819
Adv Otorhinolaryngol. 2016;79:91-102
pubmed: 27466851
Nat Neurosci. 1999 Dec;2(12):1055-62
pubmed: 10570481
Nucleic Acids Res. 2015 Apr 20;43(7):e47
pubmed: 25605792
Eur J Cancer. 1994;30A(10):1511-6
pubmed: 7833110
Trends Cell Biol. 2017 Jan;27(1):69-81
pubmed: 27746095
Am J Physiol Lung Cell Mol Physiol. 2012 Dec 1;303(11):L956-66
pubmed: 22962016
Cancer Prev Res (Phila). 2011 Dec;4(12):2122-30
pubmed: 21911444
Biochem Biophys Res Commun. 2014 Apr 4;446(2):499-503
pubmed: 24613843
Am J Physiol Lung Cell Mol Physiol. 2017 Jul 1;313(1):L154-L165
pubmed: 28450286
J Biol Chem. 2017 May 19;292(20):8484-8497
pubmed: 28373278
J Vis Exp. 2010 Dec 06;(46):
pubmed: 21189469
Trends Biochem Sci. 1993 Jun;18(6):195-7
pubmed: 8346551
Food Chem. 2014 May 1;150:27-33
pubmed: 24360415
Biosci Biotechnol Biochem. 2005 Sep;69(9):1643-51
pubmed: 16195580
Laryngoscope. 2017 Jan;127(1):44-51
pubmed: 27650657
Mol Cell Biochem. 2020 Feb;465(1-2):199-214
pubmed: 31894529
Biol Pharm Bull. 2016;39(1):33-41
pubmed: 26567724
Diabetes. 2003 Feb;52(2):356-64
pubmed: 12540608
Proc Natl Acad Sci U S A. 2002 Feb 19;99(4):2392-7
pubmed: 11854532
N Engl J Med. 2013 May 30;368(22):2059-74
pubmed: 23634996
Cancer Res. 2010 Mar 1;70(5):1925-31
pubmed: 20179194
Nat Prod Bioprospect. 2014 Dec 3;:
pubmed: 25466288
Chem Senses. 2010 Feb;35(2):157-70
pubmed: 20022913
Expert Rev Hematol. 2014 Dec;7(6):807-18
pubmed: 25227702
J Agric Food Chem. 2013 Nov 6;61(44):10454-66
pubmed: 24117141
Biol Pharm Bull. 2012;35(3):400-7
pubmed: 22382328
Nutr Cancer. 1999;35(1):80-6
pubmed: 10624710
Mol Cell Biochem. 2019 Apr;454(1-2):203-214
pubmed: 30350307
Semin Cell Dev Biol. 2013 Mar;24(3):215-21
pubmed: 22947915
Stem Cell Res Ther. 2018 Oct 25;9(1):271
pubmed: 30359303
Mol Hum Reprod. 2012 Jun;18(6):289-97
pubmed: 22266327
Integr Cancer Ther. 2016 Sep;15(3):376-89
pubmed: 26487740
PLoS One. 2008;3(12):e3974
pubmed: 19092995
Methods. 2001 Dec;25(4):402-8
pubmed: 11846609
Clin Cancer Res. 2001 Jun;7(6):1716-23
pubmed: 11410511
Cancers (Basel). 2019 Jan 10;11(1):
pubmed: 30634713
Am J Physiol Lung Cell Mol Physiol. 2016 Feb 15;310(4):L365-76
pubmed: 26684251
Oncotarget. 2016 Mar 15;7(11):12623-32
pubmed: 26862855
PLoS One. 2017 Apr 25;12(4):e0175558
pubmed: 28441391
J Cancer. 2018 Feb 1;9(4):711-725
pubmed: 29556329
J Agric Food Chem. 2013 Jan 9;61(1):53-60
pubmed: 23214402
Biochem Biophys Res Commun. 2011 Mar 4;406(1):146-51
pubmed: 21303656
Proc Natl Acad Sci U S A. 2003 Jul 22;100(15):8981-6
pubmed: 12857948
Am J Physiol Cell Physiol. 2001 Apr;280(4):C742-51
pubmed: 11245589
Cell Mol Life Sci. 2015 Jan;72(2):217-36
pubmed: 25323130
EMBO J. 1992 Mar;11(3):961-71
pubmed: 1312467
FASEB J. 2015 Jan;29(1):164-72
pubmed: 25342133
Cell Rep. 2017 Jun 6;19(10):2060-2073
pubmed: 28591578
Mol Pharmacol. 2012 Mar;81(3):328-37
pubmed: 22113078
Anticancer Res. 2008 Nov-Dec;28(6A):3701-4
pubmed: 19189652
Curr Biol. 2010 Jun 22;20(12):1104-9
pubmed: 20537538

Auteurs

Valentina Salvestrini (V)

Department of Experimental, Diagnostic and Specialty Medicine, Policlinico S. Orsola-Malpighi University Hospital, University of Bologna, Bologna, Italy.

Marilena Ciciarello (M)

Department of Experimental, Diagnostic and Specialty Medicine, Policlinico S. Orsola-Malpighi University Hospital, University of Bologna, Bologna, Italy.

Valentina Pensato (V)

Department of Experimental, Diagnostic and Specialty Medicine, Policlinico S. Orsola-Malpighi University Hospital, University of Bologna, Bologna, Italy.

Giorgia Simonetti (G)

Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori IRCCS, Meldola, Italy.

Maria Antonella Laginestra (MA)

Department of Experimental, Diagnostic and Specialty Medicine, Policlinico S. Orsola-Malpighi University Hospital, University of Bologna, Bologna, Italy.
Laboratory of Experimental Oncology, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy.

Samantha Bruno (S)

Department of Experimental, Diagnostic and Specialty Medicine, Policlinico S. Orsola-Malpighi University Hospital, University of Bologna, Bologna, Italy.

Martina Pazzaglia (M)

Department of Experimental, Diagnostic and Specialty Medicine, Policlinico S. Orsola-Malpighi University Hospital, University of Bologna, Bologna, Italy.

Elena De Marchi (E)

Department of Morphology, Surgery and Experimental Medicine, Section of Pathology, Oncology and Experimental Biology, University of Ferrara, Ferrara, Italy.

Dorian Forte (D)

Department of Experimental, Diagnostic and Specialty Medicine, Policlinico S. Orsola-Malpighi University Hospital, University of Bologna, Bologna, Italy.

Stefania Orecchioni (S)

Laboratory of Hematology-Oncology, IRCCS European Institute of Oncology, Milan, Italy.

Giovanni Martinelli (G)

Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori IRCCS, Meldola, Italy.

Francesco Bertolini (F)

Laboratory of Hematology-Oncology, IRCCS European Institute of Oncology, Milan, Italy.

Simon Méndez-Ferrer (S)

Laboratory of Hematology-Oncology, IRCCS European Institute of Oncology, Milan, Italy.
Department of Haematology, Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute, University of Cambridge, Cambridge, United Kingdom.
Centro Nacional de Investigaciones Cardiovasculares, Madrid, Spain.

Elena Adinolfi (E)

Department of Morphology, Surgery and Experimental Medicine, Section of Pathology, Oncology and Experimental Biology, University of Ferrara, Ferrara, Italy.

Francesco Di Virgilio (F)

Department of Morphology, Surgery and Experimental Medicine, Section of Pathology, Oncology and Experimental Biology, University of Ferrara, Ferrara, Italy.

Michele Cavo (M)

Department of Experimental, Diagnostic and Specialty Medicine, Policlinico S. Orsola-Malpighi University Hospital, University of Bologna, Bologna, Italy.

Antonio Curti (A)

Department of Oncology and Hematology, Institute of Hematology "L. and A. Seràgnoli", University-Hospital S.Orsola-Malpighi, Bologna, Italy.

Classifications MeSH